{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/AXSM/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:59:10.218Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8872,"canonical_name":"Axsome Therapeutics, Inc.","cik":"0001579428","uei":null,"lei":null,"duns":null,"ticker":"AXSM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":45,"open":1},"count":46,"timeline":[{"ts":"2026-07-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Axsome Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001579428/8-k/0001193125-26-304039","accession_number":"0001193125-26-304039","importance":35},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"TABUTEAU HERRIOT","title":"Chief Executive Officer","shares":49666,"price_per_share":240.25,"usd_value":11932257,"security_title":"Common Stock","importance":46.9322565},{"ts":"2026-07-01","kind":"sec.form144","reporter":"Herriot Tabuteau","title":"Officer","shares":49666,"usd_value":11952620,"security_title":"Common Stock","approx_sale_date":"2026-07-01","accession_number":"0001958244-26-000417","importance":42.390523912},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"TABUTEAU HERRIOT","title":"Chief Executive Officer","shares":49666,"price_per_share":4.95,"usd_value":245847,"security_title":"Common Stock","importance":15.2458467},{"ts":"2026-06-11","kind":"sec.form144","reporter":"JEFFS ROGER","title":"Director","shares":286,"usd_value":71248,"security_title":"Common","approx_sale_date":"2026-06-11","accession_number":"0001921094-26-000636","importance":40.0142496},{"ts":"2026-06-11","kind":"sec.insider.s","reporter":"JEFFS ROGER","title":null,"shares":286,"price_per_share":249.12,"usd_value":71248,"security_title":"Common Stock","importance":35.07124832},{"ts":"2026-06-10","kind":"sec.form144","reporter":"Coleman Mark","title":"Director","shares":643,"usd_value":160109,"security_title":"Common","approx_sale_date":"2026-06-10","accession_number":"0001921094-26-000631","importance":40.0320218},{"ts":"2026-06-10","kind":"sec.form144","reporter":"Mahony Susan","title":"Director","shares":300,"usd_value":73854,"security_title":"Common","approx_sale_date":"2026-06-10","accession_number":"0001921094-26-000633","importance":40.0147708},{"ts":"2026-06-10","kind":"sec.form144","reporter":"JEFFS ROGER","title":"Director","shares":286,"usd_value":70407,"security_title":"Common","approx_sale_date":"2026-06-10","accession_number":"0001921094-26-000632","importance":40.0140814},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Coleman Mark","title":null,"shares":643,"price_per_share":249,"usd_value":160107,"security_title":"Common Stock","importance":35.160106999999996},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Mahony Susan","title":null,"shares":300,"price_per_share":246.18,"usd_value":73854,"security_title":"Common Stock","importance":35.073854},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"JEFFS ROGER","title":null,"shares":286,"price_per_share":246.18,"usd_value":70407,"security_title":"Common Stock","importance":35.07040748},{"ts":"2026-06-10","kind":"sec.filing","form_type":"144","title":"144 — Axsome Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001579428/144/0001921094-26-000631","accession_number":"0001921094-26-000631","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — Axsome Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001579428/4/0001193125-26-266433","accession_number":"0001193125-26-266433","importance":30},{"ts":"2026-06-10","kind":"sec.insider.643","reporter":"Coleman Mark","title":null,"shares":643,"price_per_share":249,"usd_value":160107,"security_title":"Common Stock","importance":15.160107},{"ts":"2026-06-10","kind":"sec.insider.300","reporter":"Mahony Susan","title":null,"shares":300,"price_per_share":246.18,"usd_value":73854,"security_title":"Common Stock","importance":15.073854},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"TABUTEAU HERRIOT","title":"Chief Executive Officer","shares":49670,"price_per_share":241.01,"usd_value":11970967,"security_title":"Common Stock","importance":46.9709667},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Pizzie Nick","title":"Chief Financial Officer","shares":33000,"price_per_share":240.09,"usd_value":7922970,"security_title":"Common Stock","importance":42.92297},{"ts":"2026-06-09","kind":"sec.form144","reporter":"Herriot Tabuteau","title":"Officer","shares":49670,"usd_value":12200939,"security_title":"Common Stock","approx_sale_date":"2026-06-09","accession_number":"0001958244-26-000358","importance":42.44018776},{"ts":"2026-06-09","kind":"sec.form144","reporter":"Pizzie Nick","title":"Officer","shares":33000,"usd_value":7923002,"security_title":"Common","approx_sale_date":"2026-06-09","accession_number":"0001921094-26-000619","importance":41.5846004},{"ts":"2026-06-09","kind":"sec.form144","reporter":"Mahony Susan","title":"Director","shares":300,"usd_value":71163,"security_title":"Common","approx_sale_date":"2026-06-09","accession_number":"0001921094-26-000618","importance":40.0142326},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Mahony Susan","title":null,"shares":300,"price_per_share":237.21,"usd_value":71163,"security_title":"Common Stock","importance":35.071163},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Axsome Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001579428/8-k/0001193125-26-264043","accession_number":"0001193125-26-264043","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Axsome Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001579428/8-k/0001193125-26-264047","accession_number":"0001193125-26-264047","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"144","title":"144 — Axsome Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001579428/144/0001921094-26-000619","accession_number":"0001921094-26-000619","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — Axsome Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001579428/4/0001193125-26-264035","accession_number":"0001193125-26-264035","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — Axsome Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001579428/4/0001193125-26-264041","accession_number":"0001193125-26-264041","importance":30},{"ts":"2026-06-09","kind":"sec.insider.m","reporter":"TABUTEAU HERRIOT","title":"Chief Executive Officer","shares":49670,"price_per_share":4.95,"usd_value":245867,"security_title":"Common Stock","importance":15.2458665},{"ts":"2026-06-09","kind":"sec.insider.m","reporter":"Pizzie Nick","title":"Chief Financial Officer","shares":33000,"price_per_share":3.5,"usd_value":115500,"security_title":"Common Stock","importance":15.1155},{"ts":"2026-06-09","kind":"sec.insider.300","reporter":"Mahony Susan","title":null,"shares":300,"price_per_share":237.21,"usd_value":71163,"security_title":"Common Stock","importance":15.071163},{"ts":"2026-06-08","kind":"sec.insider.1429","reporter":"JEFFS ROGER","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.1429","reporter":"Saad Mark E","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.1429","reporter":"Mahony Susan","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.1429","reporter":"Coleman Mark","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.m","reporter":"JEFFS ROGER","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.m","reporter":"Saad Mark E","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.m","reporter":"Mahony Susan","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.m","reporter":"Coleman Mark","title":null,"shares":1429,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Axsome Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001579428/8-k/0001193125-26-254708","accession_number":"0001193125-26-254708","importance":35},{"ts":"2026-06-02","kind":"sec.form144","reporter":"Coleman Mark","title":"Director","shares":5537,"usd_value":1236885,"security_title":"Common","approx_sale_date":"2026-06-02","accession_number":"0001921094-26-000584","importance":40.247377},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Coleman Mark","title":null,"shares":5537,"price_per_share":223.39,"usd_value":1236910,"security_title":"Common Stock","importance":36.23691043},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Coleman Mark","title":"Director","shares":6000,"usd_value":1381798,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001921094-26-000574","importance":40.2763596},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Coleman Mark","title":null,"shares":6000,"price_per_share":230.3,"usd_value":1381800,"security_title":"Common Stock","importance":36.3818},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Axsome Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001579428/144/0001921094-26-000574","accession_number":"0001921094-26-000574","importance":30},{"ts":"2026-05-29","kind":"sec.insider.s","reporter":"Coleman Mark","title":null,"shares":6000,"price_per_share":233.46,"usd_value":1400760,"security_title":"Common Stock","importance":36.40076},{"ts":"2024-12-31","kind":"open.payments","reporter":"Axsome Therapeutics, Inc.","title":"$12225316.0 to 27126 physicians (2024–2024)","security_title":"manufacturer","excerpt":"Auvelity","accession_number":"2024","usd_value":12225316,"importance":70}]}